Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) Whether a loan licencee manufacturing pharmaceutical products in another manufacturer's factory, without owning a factory of its own, was eligible for small scale exemption under Notification No. 1/93-C.E. as the successor to Notification No. 175/86-C.E.; (ii) whether the authorities in remand proceedings could take a view contrary to the interpretation already placed on the exemption by the remanding appellate order.
Issue (i): Whether a loan licencee manufacturing pharmaceutical products in another manufacturer's factory, without owning a factory of its own, was eligible for small scale exemption under Notification No. 1/93-C.E. as the successor to Notification No. 175/86-C.E.
Analysis: The exemption under the successor notification had to be read in the light of the legal position already settled for the earlier notification. The loan licencee had no factory of its own, but the earlier Gujarat High Court ruling had treated such loan licencees as covered by the exemption. The successor notification did not justify a different result on the same legal question.
Conclusion: The loan licencee was eligible for the small scale exemption and the duty demand was not sustainable.
Issue (ii): Whether the authorities in remand proceedings could take a view contrary to the interpretation already placed on the exemption by the remanding appellate order.
Analysis: The remanding appellate order had proceeded on the basis that the Gujarat High Court ruling governed the issue and had accepted that ownership of an independent manufacturing unit was not a precondition. In the remand proceedings, a contrary view could not be adopted when the issue had already been settled for the purpose of the remand.
Conclusion: The contrary view taken in remand was impermissible.
Final Conclusion: The demand was set aside and the appellant obtained consequential relief.
Ratio Decidendi: A loan licencee manufacturing pharmaceutical products in another unit is entitled to small scale exemption where the governing notification, read in light of the controlling precedent, does not require ownership of an independent factory.